Somewhat surprisingly, Aurora Cannabis (NYSE:ACB) seems to be the center of attention for many cannabis investors. It’s the most popular pot stock on the Robinhood trading platform. Aurora’s average trading volume has been much higher than its rivals in recent weeks.
Last week’s election results, combined with better-than-expected revenue in Aurora’s fiscal year 2021 first quarter, appear to have increased investors’ optimism. But there’s a U.S. marijuana stock that’s still running circles around Aurora: Curaleaf Holdings (OTC:CURLF). Here are three key ways that Curaleaf is beating Aurora.
1. Diverging stock charts
Some investors reacted enthusiastically to Aurora’s major rebound last week and early this week. However, it was easy to tell that the good times wouldn’t keep rolling for long. Sure enough, Aurora’s share price fell dramatically over the last couple of days.
It’s important to understand that even if Aurora had kept its big recent gains, it would still badly underperform Curaleaf. The stock charts of these two cannabis companies have shown diverging paths throughout much of this year.
Aurora and Curaleaf started out 2020 with market caps of close to $3 billion, with Aurora a little under that level and Curaleaf a little over it. Now, Curaleaf’s market cap is more than four times greater than Aurora’s.